๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

International comparison of cost effectiveness of medical management strategies for nephrolithiasis

โœ Scribed by Lotan, Yair ;Cadeddu, Jeffrey A. ;Pearle, Margaret S.

Publisher
Springer
Year
2005
Tongue
English
Weight
198 KB
Volume
33
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of selection strategies for g
Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma : Effectiveness and cost-effectiveness
โœ Carolina M. Reyes; Brian A. Allen; Jonathan P. Terdiman; Leslie S. Wilson ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 273 KB ๐Ÿ‘ 2 views

## Background: Molecular testing for hereditary nonpolyposis colorectal carcinoma (hnpcc) is becoming standard care and it is cost-effective compared with no genetic testing. however, the best strategy for detection of hnpcc gene carriers is unknown. ## Methods: We use a decision analytic model t

Cost-effectiveness analysis of hepatitis
Cost-effectiveness analysis of hepatitis A vaccination strategies for adults
โœ J. Barry O'Connor; Thomas F. Imperiale; Mendel E. Singer ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

Our objective in this study was to determine the costeffectiveness of hepatitis A vaccination strategies in healthy adults in the United States. We constructed a decision model simulating costs and health consequences for otherwise healthy adults with respect to hepatitis A prevention. Three strateg

Survival and cost-effectiveness analysis
Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma
โœ Willscott E. Naugler; Amnon Sonnenberg ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 251 KB

The aim of the present study is to compare the survival rates and cost-effectiveness of different treatment strategies for small (<2 cm) hepatocellular carcinoma (HCC). Markov chains are developed to model different management strategies for patients with compensated cirrhosis and small HCC. Probabi